Ratings by Oppenheimer (Cheng Li)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/26/2026 | WAVE Life Sciences | WVE | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2025 | WAVE Life Sciences | WVE | Maintain | Outperform (N/A) |
|
Details | ||
| 7/28/2025 | WAVE Life Sciences | WVE | New Coverage | Outperform (N/A) |
8.39 (5.81) |
-30.75% | Details | |
| 2/24/2025 | Vaxart Inc. | VXRT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2024 | Vaxart Inc. | VXRT | New Coverage | Outperform (N/A) |
0.60 (0.32) |
-46.67% | Details |
